{
    "sourceOrganization": [
        {
            "@type": "ResearchProject",
            "name": "NIAID SAVE Program",
            "abstract": "SARS-CoV-2 Assessment of Viral Evolution (SAVE) provides real-time risk assessment of emerging SARS-CoV-2 mutations that may impact transmissibility and virulence. This program supports the SARS-CoV-2 Interagency Group (SIG) by evaluating viral evolution and informing public health responses.",
            "description": "To support the generation of data for the SARS-CoV-2 Interagency Group (SIG), NIAID has created the SARS-CoV-2 Assessment of Viral Evolution (SAVE) risk-assessment pipeline for SARS-CoV-2 variant viruses. SAVE provides a comprehensive real-time risk assessment of emerging mutations in SARS-CoV-2 that could impact transmissibility, virulence, and susceptibility to infection- or vaccine-induced immunity. For more information, visit the NIAID program page: https://www.niaid.nih.gov/research/sars-cov-2-assessment-viral-evolution-program",
            "alternateName": [
                "SAVE",
                "SARS-CoV-2 Assessment of Viral Evolution"
            ],
            "url": "https://www.niaid.nih.gov/research/sars-cov-2-assessment-viral-evolution-program",
            "parentOrganization": [
                "NIAID",
                "SARS-CoV-2 Interagency Group"
            ]
        }
    ]
}